Last Updated on May 02, 2015

Latest Publications and Research on Lupus Nephritis

Lupus  2020 Jan 29  

Transplant outcomes in kidney recipients with lupus nephritis, and systematic review.

Kim JE, Kim YC, Min SL, Lee H, Ha J, Chin HJ, Kim YS, Han SS

Despite improved survival of patients with lupus nephritis (LN), some require kidney transplantation because of progression to end-stage renal disease... Read More

Source: PubMed


Lupus  2020 Jan 29  

Transplant outcomes in kidney recipients with lupus nephritis, and systematic review.

Kim JE, Kim YC, Min SL, Lee H, Ha J, Chin HJ, Kim YS, Han SS

Despite improved survival of patients with lupus nephritis (LN), some require kidney transplantation because of progression to end-stage renal disease... Read More

Source: PubMed

Rheumatol Ther  2020 Feb 01  

Characteristics and Symptom Severity of Patients Reporting Systemic Lupus Erythematosus in the PatientsLikeMe Online Health Community: A Retrospective Observational Study.

Nyman E, Vaughan T, Desta B, Wang X, Barut V, Emmas C

Online health communities and research networks such as PatientsLikeMe (PLM) capture patient perspectives of diseases, including systemic lupus erythe... Read More

Source: PubMed

Adv Rheumatol    

Comparison of urinary parameters, biomarkers, and outcome of childhood systemic lupus erythematosus early onset-lupus nephritis.

Miguel DF, Terreri MT, Pereira RMR, Bonfá E, Silva CAA, Corrente JE, Magalhaes CS

Urinary parameters, anti-dsDNA antibodies and complement tests were explored in patients with childhood-Systemic Lupus Erythematosus (cSLE) early-onse... Read More

Source: PubMed

J. Nephrol.  2020 Jan 30  

Belimumab may decrease flare rate and allow glucocorticoid withdrawal in lupus nephritis (including dialysis and transplanted patient).

Binda V, Trezzi B, Del Papa N, Beretta L, Frontini G, Porata G, Fabbrini P, Pozzi MR, Messa P, Sinico RA, Moroni G

Belimumab (Benlysta) is currently approved for the treatment of active Lupus despite standard therapy. Few data are available on the efficacy of this ... Read More

Source: PubMed

Front Immunol    

TLR7 Agonism Accelerates Disease and Causes a Fatal Myeloproliferative Disorder in NZM 2410 Lupus Mice.

Wirth JR, Molano I, Ruiz P, Coutermarsh-Ott S, Cunningham MA

Murine models of lupus, both spontaneous and inducible, are valuable instruments to study SLE pathogenesis. Accelerants such as Type I IFN are often u... Read More

Source: PubMed

Rheumatol Ther  2020 Feb 01  

Characteristics and Symptom Severity of Patients Reporting Systemic Lupus Erythematosus in the PatientsLikeMe Online Health Community: A Retrospective Observational Study.

Nyman E, Vaughan T, Desta B, Wang X, Barut V, Emmas C

Online health communities and research networks such as PatientsLikeMe (PLM) capture patient perspectives of diseases, including systemic lupus erythe... Read More

Source: PubMed

Adv Rheumatol    

Comparison of urinary parameters, biomarkers, and outcome of childhood systemic lupus erythematosus early onset-lupus nephritis.

Miguel DF, Terreri MT, Pereira RMR, Bonfá E, Silva CAA, Corrente JE, Magalhaes CS

Urinary parameters, anti-dsDNA antibodies and complement tests were explored in patients with childhood-Systemic Lupus Erythematosus (cSLE) early-onse... Read More

Source: PubMed

J. Nephrol.  2020 Jan 30  

Belimumab may decrease flare rate and allow glucocorticoid withdrawal in lupus nephritis (including dialysis and transplanted patient).

Binda V, Trezzi B, Del Papa N, Beretta L, Frontini G, Porata G, Fabbrini P, Pozzi MR, Messa P, Sinico RA, Moroni G

Belimumab (Benlysta) is currently approved for the treatment of active Lupus despite standard therapy. Few data are available on the efficacy of this ... Read More

Source: PubMed

Front Immunol    

TLR7 Agonism Accelerates Disease and Causes a Fatal Myeloproliferative Disorder in NZM 2410 Lupus Mice.

Wirth JR, Molano I, Ruiz P, Coutermarsh-Ott S, Cunningham MA

Murine models of lupus, both spontaneous and inducible, are valuable instruments to study SLE pathogenesis. Accelerants such as Type I IFN are often u... Read More

Source: PubMed

Lupus  2020 Jan 29  

Transplant outcomes in kidney recipients with lupus nephritis, and systematic review.

Kim JE, Kim YC, Min SL, Lee H, Ha J, Chin HJ, Kim YS, Han SS

Despite improved survival of patients with lupus nephritis (LN), some require kidney transplantation because of progression to end-stage renal disease... Read More

Source: PubMed

Rheumatol Ther  2020 Feb 01  

Characteristics and Symptom Severity of Patients Reporting Systemic Lupus Erythematosus in the PatientsLikeMe Online Health Community: A Retrospective Observational Study.

Nyman E, Vaughan T, Desta B, Wang X, Barut V, Emmas C

Online health communities and research networks such as PatientsLikeMe (PLM) capture patient perspectives of diseases, including systemic lupus erythe... Read More

Source: PubMed

Adv Rheumatol    

Comparison of urinary parameters, biomarkers, and outcome of childhood systemic lupus erythematosus early onset-lupus nephritis.

Miguel DF, Terreri MT, Pereira RMR, Bonfá E, Silva CAA, Corrente JE, Magalhaes CS

Urinary parameters, anti-dsDNA antibodies and complement tests were explored in patients with childhood-Systemic Lupus Erythematosus (cSLE) early-onse... Read More

Source: PubMed

J. Nephrol.  2020 Jan 30  

Belimumab may decrease flare rate and allow glucocorticoid withdrawal in lupus nephritis (including dialysis and transplanted patient).

Binda V, Trezzi B, Del Papa N, Beretta L, Frontini G, Porata G, Fabbrini P, Pozzi MR, Messa P, Sinico RA, Moroni G

Belimumab (Benlysta) is currently approved for the treatment of active Lupus despite standard therapy. Few data are available on the efficacy of this ... Read More

Source: PubMed

Front Immunol    

TLR7 Agonism Accelerates Disease and Causes a Fatal Myeloproliferative Disorder in NZM 2410 Lupus Mice.

Wirth JR, Molano I, Ruiz P, Coutermarsh-Ott S, Cunningham MA

Murine models of lupus, both spontaneous and inducible, are valuable instruments to study SLE pathogenesis. Accelerants such as Type I IFN are often u... Read More

Source: PubMed

Most Popular on Medindia